日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Multiomic profiling of chronically activated CD4+ T cells identifies drivers of exhaustion and metabolic reprogramming

慢性活化 CD4+ T 细胞的多组学分析可识别衰竭和代谢重编程的驱动因素

Matthew L Lawton, Melissa M Inge, Benjamin C Blum, Erika L Smith-Mahoney, Dante Bolzan, Weiwei Lin, Christina McConney, Jacob Porter, Jarrod Moore, Ahmed Youssef, Yashasvi Tharani, Xaralabos Varelas, Gerald V Denis, Wilson W Wong, Dzmitry Padhorny, Dima Kozakov, Trevor Siggers, Stefan Wuchty, Jennif

Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial

切除接受新辅助化疗的临床淋巴结阳性乳腺癌患者的阳性淋巴结:对 ISPY-2 临床试验中腋窝手术的影响

Kayla M Switalla, Judy C Boughey, Katrina Dimitroff, Christina Yau, Velle Ladores, Hongmei Yu, Julia Tchou, Mehra Golshan, Gretchen Ahrendt, Lauren M Postlewait, Mara Piltin, Chantal R Reyna, Cindy B Matsen, Todd M Tuttle, Anne M Wallace, Cletus A Arciero, Marie Catherine Lee, Jennifer Tseng, Jennif

Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C

曾感染过 COVID-19 或 MIS-C 的儿科患者对 SARS-CoV-2 Omicron 变体的交叉反应免疫力较低

Juanjie Tang #, Tanya Novak #, Julian Hecker #, Gabrielle Grubbs #, Fatema Tuz Zahra, Lorenza Bellusci, Sara Pourhashemi, Janet Chou, Kristin Moffitt, Natasha B Halasa, Stephanie P Schwartz, Tracie C Walker, Keiko M Tarquinio, Matt S Zinter, Mary A Staat, Shira J Gertz, Natalie Z Cvijanovich, Jennif

Steroid Hormone Receptor and Infiltrating Immune Cell Status Reveals Therapeutic Vulnerabilities of ESR1-Mutant Breast Cancer

类固醇激素受体和浸润免疫细胞状态揭示 ESR1 突变乳腺癌的治疗弱点

Michelle M Williams, Nicole S Spoelstra, Spencer Arnesen, Kathleen I O'Neill, Jessica L Christenson, Jordan Reese, Kathleen C Torkko, Andrew Goodspeed, Emmanuel Rosas, Toru Hanamura, Sharon B Sams, Zheqi Li, Steffi Oesterreich, Rebecca B Riggins, Britta M Jacobsen, Anthony Elias, Jason Gertz, Jennif

Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET

Delta-24-RGD 是一种溶瘤腺病毒,可提高 AT/RT 和 CNS-PNET 模型中的存活率并促进促炎免疫景观重塑

Marc Garcia-Moure #, Marisol Gonzalez-Huarriz #, Sara Labiano, Elizabeth Guruceaga, Eva Bandres, Marta Zalacain, Lucia Marrodan, Carlos de Andrea, Maria Villalba, Naiara Martinez-Velez, Virginia Laspidea, Montse Puigdelloses, Jaime Gallego Perez-Larraya, Ignacio Iñigo-Marco, Renata Stripecke, Jennif

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma

临床特征和多平台分子分析有助于了解肾细胞癌患者对抗 PD-1/PD-L1 的反应

Eileen Shiuan, Anupama Reddy, Stephanie O Dudzinski, Aaron R Lim, Ayaka Sugiura, Rachel Hongo, Kirsten Young, Xian-De Liu, Christof C Smith, Jamye O'Neal, Kimberly B Dahlman, Renee McAlister, Beiru Chen, Kristen Ruma, Nathan Roscoe, Jehovana Bender, Joolz Ward, Ju Young Kim, Christine Vaupel, Jennif

IL1 Receptor Antagonist Controls Transcriptional Signature of Inflammation in Patients with Metastatic Breast Cancer

IL1 受体拮抗剂控制转移性乳腺癌患者的炎症转录特征

Te-Chia Wu #, Kangling Xu #, Jan Martinek #, Robyn R Young, Romain Banchereau, Joshy George, Jacob Turner, Kyung In Kim, Sandra Zurawski, Xuan Wang, Derek Blankenship, Hannah M Brookes, Florentina Marches, Gerlinde Obermoser, Elizabeth Lavecchio, Maren K Levin, Sookyoung Bae, Cheng-Han Chung, Jennif

Mutations in CNNM4 cause Jalili syndrome, consisting of autosomal-recessive cone-rod dystrophy and amelogenesis imperfecta

CNNM4 突变会导致 Jalili 综合征,包括常染色体隐性遗传的视锥细胞-视杆细胞营养不良和牙釉质形成不全症

David A Parry, Alan J Mighell, Walid El-Sayed, Roger C Shore, Ismail K Jalili, Hélène Dollfus, Agnes Bloch-Zupan, Roman Carlos, Ian M Carr, Louise M Downey, Katharine M Blain, David C Mansfield, Mehdi Shahrabi, Mansour Heidari, Parissa Aref, Mohsen Abbasi, Michel Michaelides, Anthony T Moore, Jennif